Invitrox has a total of 26 patents globally, out of which 9 have been granted. Of these 26 patents, 30% patents are active. The United States of America is where Invitrox has filed the maximum number of patents, followed by Canada and Europe (EPO). Parallelly, the United States of America seems to be the main focused R&D centre and is the origin country of Invitrox.
Invitrox was founded in 1959. Invitrox is a specialized contract research organization offering advanced diagnostic and bioanalytical services. The company focuses on developing and validating medical tests, including ELISA assays and HIV diagnostics, to support healthcare providers and researchers.
Do read about some of the most popular patents of Invitrox which have been covered by us in this article and also you can find Invitrox patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Invitrox patent portfolio.
How many patents does Invitrox have?
Invitrox has a total of 26 patents globally. These patents belong to 5 unique patent families. Out of 26 patents, 8 patents are active.
How Many Patents did Invitrox File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Invitrox Applications Filed | Invitrox Patents Granted |
| 2020 | 1 | 2 |
| 2019 | 1 | 1 |
| 2017 | 1 | 1 |
| 2016 | 2 | 3 |
| 2014 | 1 | 2 |
| 2012 | 6 | – |
| 2011 | 1 | – |
| 2010 | 2 | – |
| 2009 | 7 | – |
| 2005 | 3 | – |
How many Invitrox patents are Alive/Dead?
Worldwide Patents
How Many Patents did Invitrox File in Different Countries?
Countries in which Invitrox Filed Patents
| Country | Patents |
| United States of America | 11 |
| Canada | 4 |
| Europe (EPO) | 2 |
| Japan | 1 |
| China | 1 |
| India | 1 |
| Taiwan | 1 |
Where are Research Centers of Invitrox Patents Located?
The Research Centers of Invitrox Patents is located in the United States of America.
Best Invitrox Patents
US9423335B2 is the most popular patent in the Invitrox portfolio. It has received 20 citations so far from companies like Honeywell International, Siemens Healthcare Gmbh and SpineThera.
Below is the list of most cited patents of Invitrox:
| Publication Number | Citation Count |
| US9423335B2 | 20 |
| CN102203587A | 18 |
| US8828737B2 | 10 |
| US20060046279A1 | 4 |
| US20200150023A1 | 3 |
| US9683920B2 | 3 |
| US9459252B2 | 2 |
| US8735056B2 | 2 |
What Percentage of Invitrox US Patent Applications were Granted?
Invitrox (Excluding its subsidiaries) has filed 11 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 has been granted leading to a grant rate of 72.73%.
Below are the key stats of Invitrox patent prosecution at the USPTO.
Which Law Firms are Managing US Patents for Invitrox?
| Law Firm | Total Applications | Success Rate |
| Maynard Nexsen Pc | 10 | 80.0% |
| Hultquist Ip | 1 | 0.00% |
List of Invitrox Patents
| Invitrox Patents | Title |
| US10539496B2 | Instrument And Method For Optical Particle Sensing |
| CA2842681C | Instrument And Method For Optical Particle Sensing |
| US20200150023A1 | Instrument And Method For Optical Particle Sensing |
| US10359349B2 | Use Of Focused Light Scattering Techniques In Biological Applications |
| US20190346555A1 | Use Of Focused Light Scattering Techniques In Biological Applications |
| US9683920B2 | Use Of Focused Light Scattering Techniques In Biological Applications |
| US9459252B2 | Use Of Focused Light Scattering Techniques In Biological Applications |
| US9423335B2 | Instrument And Method For Optical Particle Sensing |
| US9404933B2 | Methods For Determining Patient Response To Anti-Platelet Aggregation Therapy |
| US8828737B2 | Use Of Focused Light Scattering Techniques In Biological Applicationa |
| US8735056B2 | Instrument And Method For Optical Particle Sensing |
| WO2013013228A1 | Methods For Determining Patient Response To Anti-Platelet Aggregation Therapy |
| WO2013013229A1 | Instrument And Method For Optical Particle Sensing |
| CA2842682A1 | Methods For Determining Patient Response To Anti-Platelet Aggregation Therapy |
| JP2012500385A5 | Using Focused Light Scattering Techniques In Biological Applications |
| EP2321629A2 | Use Of Focused Light Scattering Techniques In Biological Applications |
| CN102203587A | Use Of Focused Light Scattering Techniques In Biological Applications |
| IN1603DELNP2011A | Use Of Focused Light Scattering Techniques In Biological Applications |
| WO2010138391A3 | Instrument And Method For Optical Particle Sensing |
| WO2010017001A3 | Use Of Focused Light Scattering Techniques In Biological Applications |
| TW201017149A | Use Of Focused Light Scattering Techniques In Biological Applications |
| CA2733296A1 | Use Of Focused Light Scattering Techniques In Biological Applications |
| EP1799841A2 | Analytical Methods Utilizing Real-Time Energy/Particle Interaction-Based Determination Techniques |
| US20060046279A1 | Analytical Methods Utilizing Real-Time Energy/Particle Interaction-Based Determination Techniques |
| WO2006023965A2 | Analytical Methods Utilizing Real-Time Energy/Particle Interaction-Based Determination Techniques |
| CA2578145A1 | Analytical Methods Utilizing Real-Time Energy/Particle Interaction-Based Determination Techniques |
What are Invitrox key innovation segments?
What Technologies are Covered by Invitrox?
The chart below distributes patents filed by Invitrox in different countries on the basis of the technology protected in patents. It also represents the markets where Invitrox thinks it’s important to protect particular technological inventions.
R&D Focus: How has Invitrox search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Invitrox?
